Secondary Prevention for Atherosclerotic Cardiovascular Disease-Recent Trial Data and Guideline Recommendations

Recent Trial Data and Guideline Recommendations

Video Transcription

Video Summary

This video transcript discusses the importance of optimal prevention and secondary prevention for patients with established cardiovascular disease. It highlights the gaps in care for these patients and the need for guideline-directed lipid-lowering therapy. The transcript discusses various treatment options for managing lipids, including statins, PCSK9 inhibitors, omega-3 fatty acids, and others. It emphasizes the updated lipid goals for atherosclerotic cardiovascular disease, targeting LDL levels of less than 55 for high-risk patients. The transcript also provides an algorithm for managing lipid therapy based on the ACC expert consensus decision pathway. It concludes by highlighting the benefits of statin therapy in reducing cardiovascular events and the different levels of LDL reduction achieved with different statins.

Asset Subtitle

Faisal Latif, MD, FSCAI

Keywords

lipid-lowering therapy

statins

PCSK9 inhibitors

LDL levels

atherosclerotic cardiovascular disease